The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.

The new cobas ® 6800/8800 Systems version 2.0 and software version 2.0.1 enhances throughput, run flexibility, enables sample prioritization and is available as an upgrade to existing systems.

(RTTNews) - Roche Holding AG (RHHBY.PK), Tuesday announced the launch of the new cobas 6800/8800 systems version 2.0 and software version 2.0.1, supporting a more streamlined diagnostics experience.

The FINANCIAL — Roche announced on October 19 that it has received FDA approval for the cobas HBV and cobas HCV viral load tests, the first assays approved by the United States Food and Drug ...

Swiss biotech company Roche announced on December 21, 2015 that the FDA has approved the Cobas® 6800 and 8800 Systems from its Pleasanton, California-based Roche Molecular Diagnostics (RMD) for the ...

Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...

The Food and Drug Administration approved Basel, Switzerland-based Roche’s cobasMPX test to be used with the cobas 6800 and 8800 systems, according to StreetInsider. The cobas 6800 and 8800 systems ...

Roche has received 510(k) clearance with a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver from the US Food and Drug Administration (FDA) for its cobas liat sexually transmitted ...

INDIANAPOLIS, Dec. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software version 2.0.1, following U.S.